Is It Time for Total Neoadjuvant Therapy for Patients With Resectable Pancreatic Adenocarcinoma?
Fox Chase Cancer Center and Temple University School of Medicine, Philadelphia, PA JP_Hoffman@fccc.edu.
John P
JP
Hoffman
Fox Chase Cancer Center and Temple University School of Medicine, Philadelphia, PA.
Sanjay S
SS
Reddy
D000230:Adenocarcinoma; D006801:Humans; D020360:Neoadjuvant Therapy; D010190:Pancreatic Neoplasms